MGAM and bronchopulmonary dysplasia: While we did not perform molecular docking in this study, these established principles of protein–ligand interactions provide a foundation for understanding how the identified compounds may interfere with the biological activities of MMP9 and MGAM that contribute to bronchopulmonary dysplasia pathogenesis.